These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 385948)
1. Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia. Alsabti EA; Taleb AM; Raji HM; Kalil OZ; Saleh KA Jpn J Exp Med; 1979 Jun; 49(3):157-68. PubMed ID: 385948 [TBL] [Abstract][Full Text] [Related]
2. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse. Powles R; Toy JL Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466 [TBL] [Abstract][Full Text] [Related]
3. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
4. The role of immunotherapy in acute myelogenous leukemia. Foon KA; Smalley RV; Riggs CW; Gale RP Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818 [TBL] [Abstract][Full Text] [Related]
5. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine. Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786 [TBL] [Abstract][Full Text] [Related]
6. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891 [TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy of acute myelogenous leukemia (AML) in adults with the Nocardia rubra cell wall skeleton]. Ohno R; Nakamura H; Kodera Y; Masaoka T; Yamada K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1264-9. PubMed ID: 3524463 [TBL] [Abstract][Full Text] [Related]
8. A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia. Ohino R; Ueda R; Imai Kato Y; Watanabe E; Morishima Y; Yokomaku S; Kobayashi M; Takeyama H; Ezaki K; Kawashima K; Hirano M; Ohara K; Kosaki T; Yoshikawa S; Yamada K Gan; 1978 Apr; 69(2):179-86. PubMed ID: 355038 [TBL] [Abstract][Full Text] [Related]
9. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens. Greiner J; Döhner H; Schmitt M Haematologica; 2006 Dec; 91(12):1653-61. PubMed ID: 17145602 [TBL] [Abstract][Full Text] [Related]
10. Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy. Granatek CH; Ezaki K; Hersh EM; Keating MJ; Rasmussen S Cancer; 1981 Jan; 47(2):272-9. PubMed ID: 7006793 [TBL] [Abstract][Full Text] [Related]
11. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275 [TBL] [Abstract][Full Text] [Related]
12. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286 [TBL] [Abstract][Full Text] [Related]
13. Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells. Greiner J; Bullinger L; Guinn BA; Döhner H; Schmitt M Clin Cancer Res; 2008 Nov; 14(22):7161-6. PubMed ID: 19010831 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
15. [The frequency profile of tuberculin skin testing among students in nursing school]. Fujino T; Abe Y; Miyata A; Suzuki K Kekkaku; 1999 Jun; 74(6):493-7. PubMed ID: 10423960 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules. Sokal JE; Aungst CW; Snyderman M; Gomez G Ann N Y Acad Sci; 1976; 277(00):367-83. PubMed ID: 1069556 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in the management of myelogenous leukemia. Fairley GH Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]